| Total | Sex | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
 | Sample Population (n = 2656) Type 2 diabetes cases (n = 455) | Male (n = 948) Type 2 diabetes cases (n = 169) | Female (n = 1708) Type 2 diabetes cases (n = 286) | |||||||||
Continuous Adipokines | Model 1* | Model 2†| Model 1* | Model 2†| Model 1* | Model 2†| ||||||
HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | HR | 95% CI | |
Log Leptin (ng/mL) | 1.29 | (1.05, 1.58) | 0.99 | (0.80, 1.22) | 1.33 | (1.05, 1.69) | 1.00 | (0.78, 1.28) | 1.24 | (0.94, 1.64) | 0.99 | (0.74, 1.31) |
Log Adiponectin (ng/mL) | 0.57 | (0.49, 0.67) | 0.73 | (0.61, 0.86) | 0.68 | (0.52, 0.88) | 0.80 | (0.62, 1.04) | 0.52 | (0.42, 0.63) | 0.68 | (0.55, 0.84) |